| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +257.06% | $62.00 | $221.38 | 2025-08-08 - 2026-01-06 | Buy |
Cidara Therapeutics IncCDTX | +140.58% | $90.50 | $217.71 | 2025-09-26 - 2025-11-14 | Buy |
Cidara Therapeutics IncCDTX | +110.92% | $103.22 | $217.71 | 2025-10-21 - 2025-11-14 | Buy |
Cidara Therapeutics IncCDTX | +96.56% | $110.76 | $217.71 | 2025-10-09 - 2025-11-14 | Buy |
Pasithea Therapeutics CorpKTTA | +13.73% | $0.51 | $0.58 | 2026-06-16 - 2026-09-04 | Buy |
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Moleculin Biotech IncMBRX | 5 | Buy | $3.00 | +322.54% | Maintains | 8 days ago |
Curis IncCRIS | 3 | Buy | $43.00 | +3,085.19% | Reiterates | 19 days ago |
Pasithea Therapeutics CorpKTTA | 3 | Buy | $3.00 | +417.24% | Reiterates | 3 months ago |
Tvardi Therapeutics IncTVRD | 1 | Buy | $9.00 | +371.20% | Initiates Coverage On | 3 months ago |
Cidara Therapeutics IncCDTX | 5 | Hold | N/A | N/A | Downgrades | 10 months ago |